Aim and Scope

JIPAAS welcomes original research articles, review articles, systematic reviews, meta-analyses, short communications, case reports, technical notes, perspectives, editorials, and letters to the editor.

JIPAAS considers original submissions across eight core subject clusters. A manuscript need not confine itself to one — interdisciplinary work is actively encouraged. We welcome manuscripts across disciplines on topics such as:

Pharmaceutics & Pharmaceutical Technology

Drug delivery systems, novel dosage forms, nanoparticulate carriers, biopharmaceutics, formulation development, stability science, and process technology.

Pharmaceutical & Medicinal Chemistry

Drug design and synthesis, structure–activity relationships, computational and molecular modelling, QSAR, and analytical method development, Green Chemistry

Pharmacology & Toxicology

Preclinical and clinical pharmacology, mechanism-of-action studies, drug safety, pharmacovigilance, and toxicological risk assessment.

Pharmacognosy & Phytochemistry

Natural product isolation and characterization, ethnopharmacology, herbal standardization, and traditional-medicine evidence synthesis.

Pharmaceutical Biotechnology

Biologics and biosimilars, vaccine development, genomics, proteomics, and recombinant DNA technology applied to therapeutics.

Clinical & Hospital Pharmacy

Pharmaceutical care, medication safety and reconciliation, therapeutic drug monitoring, and pharmacy practice research.

Pharmacoepidemiology, Pharmacoeconomics & Regulatory Affairs

Real-world evidence, cost-effectiveness analysis, health-technology assessment, and drug regulatory science and policy.

Allied & Interdisciplinary Health Sciences

Nursing pharmacotherapeutics, clinical nutrition and dietetics, public health, and biomedical laboratory science at the point of intersection with pharmacotherapy.

Article Types Accepted

•     Original Research Article

•     Review Article

•     Systematic / Narrative Review

•     Short Communication

•     Case Report

•     Perspective / Commentary

•     Letter to the Editor

•     Study Protocol

•     Editorial (invited)